Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT07380919

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07380919
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07380919. Randomized; no masking; primary purpose treatment. Start 2026-02 (anticipated); primary completion 2026-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study
Acronym
INaMICRON
Condition
STEMI (ST Elevation MI)
Intervention (Drug)
Ranolazine
Lead sponsor
Federico II University (class: other)
Collaborator
Università Magna Grecia, Catanzaro (class: not stated)
Collaborator
Santa Maria Goretti Hospital, Latina (class: not stated)

Record details

Record id
cardio:ct-nct07380919
Content hash
19cce98f459d83ed66866552c1fbd6fecaf4dba3b424a8f8a6861af4926d7b78